Back to Search
Start Over
59Fe study of red blood cells life span in glucose-6-phosphate dehydrogenase deficiency heterozygote
- Source :
- Human Genetics. 5
- Publication Year :
- 1968
- Publisher :
- Springer Science and Business Media LLC, 1968.
-
Abstract
- In a presumptive heterozygote for congenital nonspherocytic hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency, a fraction of short-living red blood cells was demonstrated by administration of nitrofurantoin in the 22nd day of the 59Fe study of erythrocyte life span. A small percentage of deficient red blood cells in peripheral blood in this case (4%) may originate in the shorter life span of deficient cells and in the proportion of the deficient to normal red blood cells produced.
- Subjects :
- Heterozygote
medicine.medical_specialty
Life span
Heterozygote advantage
Erythrocyte Aging
Biology
medicine.disease
Iron Isotopes
Molecular medicine
Peripheral blood
Dehydrogenase deficiency
Glucosephosphate Dehydrogenase Deficiency
Congenital nonspherocytic hemolytic anemia
Endocrinology
Nitrofurantoin
Internal medicine
Immunology
Genetics
medicine
Humans
Female
Genetics (clinical)
Aged
Glucose-6-phosphate dehydrogenase deficiency
medicine.drug
Subjects
Details
- ISSN :
- 14321203 and 03406717
- Volume :
- 5
- Database :
- OpenAIRE
- Journal :
- Human Genetics
- Accession number :
- edsair.doi.dedup.....4a62e993ee1102d253a002cb0113efac
- Full Text :
- https://doi.org/10.1007/bf00281960